Alcohol Use Disorders in Europe & Central Asia
How Alcohol Use Disorders affects 58 countries in Europe & Central Asia.
| # | Country | Share (%) |
|---|
Across the 52 countries in Europe & Central Asia tracked in this dataset, alcohol use disorders accounts for an average of 0.5% of total deaths. The regional average of 0.5% is notably higher than the global average of 0.4%, indicating that Europe & Central Asia carries a disproportionate burden of alcohol use disorders mortality relative to the world. In Europe & Central Asia, alcohol use disorders mortality is notably elevated, driven in part by ageing demographics, lifestyle risk factors such as alcohol and tobacco use, and variation in healthcare quality between Western and Eastern Europe.
Europe and Central Asia benefit from relatively strong health systems and high physician density, but face ageing populations, rising non-communicable disease burdens, and persistent East-West health outcome gradients. Within Europe & Central Asia, significant variation exists. Belarus records the highest share at 2.2% of total deaths, while Monaco has the lowest at 0.01%. This 2.2 percentage-point spread reflects differences in exposure, health system capacity, demographic structure, and risk factor prevalence across the region. Country-level pages provide detailed mortality breakdowns, time trends, and comparisons for each nation.
The WHO's SAFER initiative outlines five high-impact strategies: strengthening restrictions on alcohol availability, advancing and enforcing drink-driving countermeasures, facilitating access to screening and brief interventions, enforcing bans on alcohol advertising and promotion, and raising prices through taxation. Minimum unit pricing, implemented in Scotland and parts of Canada, has demonstrated reductions in alcohol-related hospitalisations and deaths. Treatment for alcohol use disorder includes pharmacotherapy (naltrexone, acamprosate, disulfiram) alongside psychosocial interventions such as cognitive behavioural therapy and mutual support groups.
The mortality estimates presented on this page are derived from the Global Burden of Disease (GBD) study, produced by the Institute for Health Metrics and Evaluation (IHME). The GBD synthesizes data from vital registration systems, verbal autopsies, cancer registries, and surveillance networks across more than 200 countries and territories. Death rates are expressed per 100,000 population and are age-standardized, which adjusts for differences in age structure between populations so that comparisons across countries and over time reflect genuine differences in mortality risk rather than demographic composition.
The dataset typically covers the period from 1990 to 2023, although availability varies by country and cause. When interpreting the figures for alcohol use disorders in Europe & Central Asia, note that higher age-standardized rates indicate a greater mortality burden independent of whether a country's population is older or younger. Trends over time reveal whether public health interventions, economic development, and health system improvements have reduced or increased the toll of this condition in the region.
The cause-of-death categories used on this page follow the Global Burden of Disease cause hierarchy, a standardized classification that groups individual ICD-coded causes into clinically meaningful categories. The "share of deaths" metric shows what percentage of all deaths in a given country or region are attributed to alcohol use disorders. A rising share does not necessarily mean more people are dying from this cause — it may reflect success in reducing competing causes of death. Always examine both absolute rates and shares for a complete picture of mortality patterns in Europe & Central Asia.